Clinical Trials Results - National Cancer Institute

Skip to content

NCI Home

Cancer Topics

Clinical Trials

Cancer Statistics

Research & Funding

News

About NCI


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -4 of 4 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase II Evaluation of Trifluoperazine to Overcome Doxorubicin Resistance in Patients with Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 to 70				NCI				YALE-HIC-3909 NCI-T86-0181D, T86-0181


2.		Phase II Chemotherapy with BLEO plus Chemopotentiation with Trifluoperazine in Patients with Malignant Brain Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 to 70								YALE-HIC-3839 NCI-V86-0093

Last Modified: 5/1/1992


3.		Phase I/II Pilot Study of Trifluoperazine and Continuous Infusion Vinblastine in Women with Advanced Breast Cancer Refractory to Initial Treatment (Summary Last Modified 05/92)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								YALE-HIC-4951 NCI-V89-0226

Last Modified: 4/1/1993


4.		Phase II Study of DOX/VBL Combined with P-Glycoprotein Inhibitors (Trifluoperazine and Verapamil) in Patients with Advanced Renal Cell Carcinoma (Summary Last Modified 04/93)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				adult				NCI				SWOG-9104 SWOG-9104

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute